Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha-antagonists and phenylephrine-induced mydriasis in healthy volunteers
NCT02266537Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 2005
- Primary completion
- Feb 2006
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of tamsulosin, alfuzosin and doxazosin in benign prostatic hyperplasia (BPH), sponsored by Boehringer Ingelheim. Started Nov 2005; status: completed.
02
Drugs
tamsulosinalfuzosindoxazosin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT02266537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02266537.